Bearing in mind that sarcopenia is a frequent and prominent finding in this patient population, maintenance of protein balance is crucial to avoid further aggravation of sarcopenia. In addition to a thorough assessment of the nutritional status of these patients 6 before implantation of the alfapump, nutritional deficits should be counterbalanced and especially insufficient protein intake compensated with an increased protein intake as recommended in cirrhotic patients. 7 The potential benefit of regular albumin replacement as suggested in the editorial should be investigated in a prospective trial.
Overall, there is a clear need for further technical improvement of the alfapump system, and this has already been achieved in part by the new peritoneal catheter that has virtually eliminated the blockage of the peritoneal catheter (internal analysis of the producer). In addition to technical improvement, management of patients with an alfapump has to be improved to further decrease the rate of complications. 
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